Sign In to Follow Application
View All Documents & Correspondence

Novel Method For Preparing Stabilized And Bioavailable Allicin 1%

Abstract: Allicin is the major biologically active component of garlic (Allium sativum) and the key ingredient responsible for the broad-spectrum of antibacterial activity in garlic. It exhibits antifungal, antiviral and antiprotozoal activity and responsible for lipid-lowering, anti-blood coagulation, anti-hypertension, anti-cancer, antioxidant and anti-microbial effects. The Allicin generated is very unstable and quickly changes into a series of other sulfur containing compounds such as diallyl disulfide. Here we demonstrate a novel extraction method and encapsulation with 6eta-Cyclodextrin allows recovering the Allicin up to 1-1.5%.

Get Free WhatsApp Updates!
Notices, Deadlines & Correspondence

Patent Information

Application #
Filing Date
26 June 2015
Publication Number
02/2017
Publication Type
INA
Invention Field
BIOTECHNOLOGY
Status
Email
Parent Application

Applicants

PLANT LIPIDS PRIVATE LIMITED
KOLENCHERY, COCHIN,

Inventors

1. SREERAJ GOPI
PLANT LIPIDS PRIVATE LIMITED, KOLENCHERY, COCHIN,
2. KARTHICK VARMA A.C
PLANT LIPIDS PRIVATE LIMITED, KOLENCHERY, COCHIN,
3. JOBY JACOB
PLANT LIPIDS PRIVATE LIMITED, KOLENCHERY, COCHIN,

Specification

1. Field of Invention

A novel method for preparing Stabilized and Bio-available allicin 1%

BACKGROUND OF THE INVENTION:
Allicin from garlic (Allium sativum) has antibacterial, antifungal,. antiviral and antiprotozoal activity and responsible for many health benefits. Allicin is of increasing interest in the search for new nutraceutical ingredients and natural medicines. Allicin in its pure form was found to exhibit antibacterial activity against a wide range of Gram-negative and Gram-positive bacteria, including multidrug-resistant enterotoxicogenic strains of Escherichia coli, antifungal activity against Candida albicans and antiparasitic activity including some major human intestinal protozoan parasites such as Entamoeba histolytica and Giardia lamblia. The main antimicrobial effect of allicin is due to its chemical reaction with thiol groups of various enzymes, e.g. alcohol dehydrogenase, thioredoxin reductase, and RNA polymerase, which can affect essential metabolism of cysteine proteinase activity involved in the virulence of E. histolytica.

2. SUMMARY OF THE INVENTION:

The invention relates the stability of allicin by encapsulation with beta-cyclddextrin. Cyclodextrins are a family of cyclic oligosaccharides with a hydrophilic outer surface and a liphophilic central cavity. Cyclodextrin molecules are relatively large with a number of hydrogen donors and acceptors and, thus, in general they do not permeate liphophilic membranes. Cyclodextrins are widely used as 'molecular cages' in the pharmaceutical, food and cosmetic industries. Beta-Cyclodextrin is used as complexing agent to increase the aqueous solubility, bioavailability and stability. The allicin molecules can be entrapped in cyclodextrin liphophilic cage; hence the allicin-cyclodextrin matrix thus has more bio¬availability, solubility and stability.

3. DESCRIPTION OF THE INVENTION:
The structure of Allicin is depicted below:
The novel extraction process is mentioned below: .
Ingredients Used: Garlic Juice Extract Beta-cyclodextrin

I Claim,

1. A novel method for preparing Stabilized and Bio-available allicin 1%

2. A product according to claim 1 , for preparing stable Allicin 1%

3. A product according to claim 1 , which can be used for treating cholesterol

4. A product according to claim , which can be used for antibacterial activity.

Documents

Application Documents

# Name Date
1 3216-CHE-2015 ABSTRACT 26-06-2015.pdf 2015-06-26
1 3216-CHE-2015 FORM-2 26-06-2015.pdf 2015-06-26
2 3216-CHE-2015 CLAIMS 26-06-2015.pdf 2015-06-26
2 3216-CHE-2015 FORM-1 26-06-2015.pdf 2015-06-26
3 3216-CHE-2015 DESCRIPTION (COMPLETE) 26-06-2015.pdf 2015-06-26
4 3216-CHE-2015 CLAIMS 26-06-2015.pdf 2015-06-26
4 3216-CHE-2015 FORM-1 26-06-2015.pdf 2015-06-26
5 3216-CHE-2015 ABSTRACT 26-06-2015.pdf 2015-06-26
5 3216-CHE-2015 FORM-2 26-06-2015.pdf 2015-06-26